Literature DB >> 4285554

Effects of 6-diazo-5-oxol-norleucine and other tumor inhibitors on the biosynthesis of nicotinamide adenine dinucleotide in mice.

R K Barclay, M A Phillipps.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4285554

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

Review 1.  Targeting Cancer Metabolism and Current Anti-Cancer Drugs.

Authors:  Witchuda Sukjoi; Jarunya Ngamkham; Paul V Attwood; Sarawut Jitrapakdee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Pharmacokinetic and phase I study of intravenous DON (6-diazo-5-oxo-L-norleucine) in children.

Authors:  M P Sullivan; J A Nelson; S Feldman; B Van Nguyen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 3.  Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy.

Authors:  Diana Cervantes-Madrid; Yair Romero; Alfonso Dueñas-González
Journal:  Biomed Res Int       Date:  2015-09-06       Impact factor: 3.411

4.  Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA).

Authors:  K Thangavelu; Qing Yun Chong; Boon Chuan Low; J Sivaraman
Journal:  Sci Rep       Date:  2014-01-23       Impact factor: 4.379

5.  An efficient synthetic route to l-γ-methyleneglutamine and its amide derivatives, and their selective anticancer activity.

Authors:  Md Imran Hossain; Ajit G Thomas; Fakhri Mahdi; Amna T Adam; Nicholas S Akins; Morgan M Woodard; Jason J Paris; Barbara S Slusher; Hoang V Le
Journal:  RSC Adv       Date:  2021-02-10       Impact factor: 3.361
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.